Aetna (AET) Q3 Earnings Set To Beat Estimates: Here's Why
Zacks Investment Research | Oct 25, 2016 04:47AM ET
Health insurer Aetna Inc. (NYSE:AET) is scheduled to release third-quarter financial results before the market opens on Oct 27.
In the last reported quarter, the company beat the earnings estimate by 4.74%. Moreover, the company posted a positive earnings surprise in each of the last four quarters, with an average beat of 7.31%. Let’s see how things are shaping up for this announcement.
Why a Likely Positive Surprise?
Our proven model shows that Aetna is likely to beat on earnings as it has the right combination of two key components. Note that a stock needs to have both a positive Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
Zacks Rank: Aetna carries a Zacks Rank #3, which increases the predictive power of ESP.
Factors to Drive Q3 Results
We expect Aetna’s third earnings to see an upside from its Government business, which continues to be its key source of growth. Government premiums now represent nearly 50% of the company’s total healthcare premiums and this business continues to outperform.
More specifically, within the government business, the company’s Medicare business is expected to show a superior performance, driven by strong membership growth. The investments made by the company in its value-based care models for Medicare Advantage beneficiaries should drive its financial performance.
We also expect to see a decline in operating expense ratio as a result of the company’s strong commitment to drive productivity improvements and its disciplined focus on managing its operating costs.
Nevertheless earnings will see a bump from ACA small group and individual products continue to be challenged by a deterioration of the risk pool and an ineffective risk adjustment mechanism.
Membership declines in the company’s Commercial Insured products will likely be due to attrition in its individual and small group membership.
We also expect to see favorable prior-year reserve development across all of its core products which should lift its earnings.
However, the bottom line will be hurt by the absence of any share buyback during the third quarter due to the proposed Humana (NYSE:HUM) acquisition.
AETNA INC-NEW Price and EPS Surprise
Tenet Healthcare Corp. (NYSE:THC) has an Earnings ESP of +26.32% and a Zacks Rank #2. The company is expected to report third-quarter earnings results on Oct 31.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has an Earnings ESP of +12.5% and a Zacks Rank #3. The company is expected to report third-quarter earnings results on Nov 1.
Confidential from Zacks
Get The News You Want
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.